U.S. FDA approves BioDelivery's drug for opioid dependence

class="mandelbrot_refrag">BioDelivery Sciences International Inc said it had received U.S. regulatory approval for its drug, Bunavail, to treat opioid dependence.

_0">

The company's shares rose 8.5 percent to $10.85 in extended trading on Friday.

BioDelivery said it expects to launch the drug late in the third quarter ending Sept. 30.

 
 
 

Opioid dependence affects more than 2 million people in the United States.

(Reporting by Shailesh Kuber in Bangalore; Editing by Maju Samuel)

Popular posts from this blog

Study Abroad USA, College of Charleston, Popular Courses, Alumni

Edinburgh Napier University Admission Process

It's 'baa'... not 'bark'! Lamo the sheep is so convinced he's a dog